Physician profile
Mona Brenner
NPI 1225603160
$4,924.94
in general payments reported to CMS, 2019-2025
36 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what 85% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $1,101 · 2023: $1,366 · 2024: $1,103 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,497 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,496.95 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $555.56 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $498.46 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $352.88 | 2021-2025 | Lifevest |
| Amgen INC. | $331.96 | 2022-2024 | Repatha |
| Novo Nordisk INC | $250.50 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $233.78 | 2022-2025 | Farxiga, Wainua, Andexxa |
| Abbott Laboratories | $222.33 | 2022-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $211.43 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $208.52 | 2021-2025 | Watchman Flx |
| Scpharmaceuticals INC. | $200.62 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $196.19 | 2022-2025 | Verquvo |
| Pfizer INC. | $160.79 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $142.48 | 2024-2025 | Onpattro |
| Kestra Medical Technology Services, INC. | $130.67 | 2022-2025 | Assure Wcd |
| Medtronic, INC. | $119.82 | 2022-2024 | Ffrangio |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $116.64 | 2022-2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $114.52 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $94.15 | 2022-2023 | Zio Xt Patch |
| Medicomp INC | $90.38 | 2022-2023 | Telepatch Cardiac Monitor |
| Actelion Pharmaceuticals US, INC. | $85.11 | 2024 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $83.57 | 2022-2025 | Evkeeza |
| W. L. Gore & Associates, INC. | $80.55 | 2021 | |
| Esperion Therapeutics, INC. | $70.53 | 2023-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $52.32 | 2022-2024 | Livalo |
| Kiniksa Pharmaceuticals, LTD. | $45.33 | 2022-2023 | Arcalyst |
| Bard Peripheral Vascular, INC. | $38.74 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.40 | 2024-2025 | |
| Baxter Healthcare | $31.56 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Atricure, INC. | $29.84 | 2022 | |
| Siemens Medical Solutions USA, INC. | $25.35 | 2023 | Artis Icono Floor |
| Cardiac Dimensions, INC. | $24.43 | 2025 | |
| Lantheus Medical Imaging, INC. | $23.29 | 2023 | Definity |
| Sanofi-Aventis U.S. LLC | $21.52 | 2023 | |
| Azurity Pharmaceuticals, INC. | $16.60 | 2024 | Edarbi |
| Glaxosmithkline, LLC. | $16.21 | 2025 | Arexvy, Shingrix |
| Abiomed | $14.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.